Search

everythinglearnresearchcommunity

for

Search:↓

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Testosterone may slow down wound healing and increase inflammation.

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Treatment during development affects hormone balance and sexual behavior in male rats.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Certain gene variations are linked to better memory in healthy Chinese women.

Androgens can help prevent memory problems caused by apoE4.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Sebocytes play a key role in controlling androgen levels in human skin.

Finasteride safely lowers DHT levels without affecting testosterone.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.